Shingo Hatakeyama
Papers
12
Total Citations
206
H-Index
11
About
Shingo Hatakeyama is a urological surgeon and clinical researcher whose work spans two major domains: minimally invasive surgery for urological cancers and geriatric oncology. Based at a leading Japanese institution, Hatakeyama has made significant contributions to the advancement of robot-assisted radical cystectomy (RARC) for muscle-invasive bladder cancer, pioneering techniques such as the cross-folded U-configuration intracorporeal ileal neobladder and rigorously comparing intracorporeal versus extracorporeal urinary diversion approaches. His surgical research, which has garnered over 90 combined citations across these studies, has helped establish evidence-based frameworks for optimizing perioperative and long-term functional outcomes in bladder cancer patients across Asia and beyond. Equally notable is Hatakeyama's commitment to geriatric urology. His prospective application of the Geriatric 8 frailty screening tool in prostate cancer patients — his most-cited work with 40 citations — has meaningfully shaped how clinicians assess surgical candidacy in older populations. His innovative exploration of cell-free DNA as a biomarker for surgical tissue damage further reflects his translational research vision. Through his involvement in Japan's National Clinical Database Urology Division, Hatakeyama continues to influence national surgical quality standards, cementing his reputation as a versatile and impactful figure in contemporary urological oncology.
Research Focus
Key Achievements
Top Papers
- 1Geriatric 8 screening of frailty in patients with prostate cancer40 citations · 2020
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10